Angiodynamics to report fiscal 2024 first quarter financial results on october 4, 2023

Latham, n.y.--(business wire)--angiodynamics, inc. (nasdaq: ango), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients, today announced that it will report financial results for the first quarter of fiscal year 2024 before the market open on wednesday, october 4, 2023. the company's management will host a conference call at 8:00 a.m. et the sam.
ANGO Ratings Summary
ANGO Quant Ranking